[go: up one dir, main page]

AU2001257406A1 - Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 - Google Patents

Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941

Info

Publication number
AU2001257406A1
AU2001257406A1 AU2001257406A AU5740601A AU2001257406A1 AU 2001257406 A1 AU2001257406 A1 AU 2001257406A1 AU 2001257406 A AU2001257406 A AU 2001257406A AU 5740601 A AU5740601 A AU 5740601A AU 2001257406 A1 AU2001257406 A1 AU 2001257406A1
Authority
AU
Australia
Prior art keywords
cardiovascular
diagnosis
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001257406A
Inventor
Katherine A. Galvin
Laura A. Rudolph-Owen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001257406A1 publication Critical patent/AU2001257406A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001257406A 2000-04-26 2001-04-25 Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 Abandoned AU2001257406A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19990800P 2000-04-26 2000-04-26
US60/199,908 2000-04-26
US63552100A 2000-08-09 2000-08-09
US09/635,521 2000-08-09
PCT/US2001/013788 WO2001081634A2 (en) 2000-04-26 2001-04-25 Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941

Publications (1)

Publication Number Publication Date
AU2001257406A1 true AU2001257406A1 (en) 2001-11-07

Family

ID=26895283

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001257406A Abandoned AU2001257406A1 (en) 2000-04-26 2001-04-25 Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941

Country Status (4)

Country Link
US (1) US20040091929A1 (en)
EP (1) EP1280937A2 (en)
AU (1) AU2001257406A1 (en)
WO (1) WO2001081634A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232056A1 (en) 1999-09-10 2003-12-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6710170B2 (en) 1999-09-10 2004-03-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
AU6531101A (en) * 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030120040A1 (en) 2001-06-29 2003-06-26 Genentech, Inc. Secreted and Transmembrane polypeptides and nucleic acids encoding the same
ATE494550T1 (en) 2003-04-25 2011-01-15 Takeda Pharmaceutical NEW SCREENING PROCESS
US20080038247A1 (en) * 2003-05-05 2008-02-14 Bayer Healthcare Ag Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39)
WO2005103283A1 (en) 2004-04-23 2005-11-03 Takeda Pharmaceutical Company Limited Novel method of screening
AU2005311321A1 (en) * 2004-12-01 2006-06-08 Janssen Pharmaceutica N.V. G protein coupled receptor
WO2007024752A2 (en) * 2005-08-26 2007-03-01 Beth Israel Deaconess Medical Center Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
AR059900A1 (en) 2006-03-17 2008-05-07 Genentech Inc ANTI-TAT226 ANTIBODIES AND IMMUNOCATE PLAYERS
EP2030024A1 (en) * 2006-06-08 2009-03-04 Janssen Pharmaceutica N.V. G protein coupled receptor 39 (gpr39)
US20120282230A1 (en) * 2009-10-21 2012-11-08 Kimberly Drenser Methods and compositions for diagnosis and treatment of genetic and retinal disease
US12268692B2 (en) 2020-04-10 2025-04-08 Postsurgical Therapeutics, Inc. Combinatorial targeted therapy methods
WO2021207727A1 (en) * 2020-04-10 2021-10-14 Postsurgical Therapeutics, Inc. Combinatorial targeted therapy methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2370489A1 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 49 human secreted proteins
CA2402834A1 (en) * 2000-03-23 2001-09-27 Immusol Incorporated Brca-1 regulators and methods of use

Also Published As

Publication number Publication date
WO2001081634A3 (en) 2002-09-12
US20040091929A1 (en) 2004-05-13
WO2001081634A2 (en) 2001-11-01
EP1280937A2 (en) 2003-02-05

Similar Documents

Publication Publication Date Title
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
EP0808324A4 (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU2001249329A1 (en) Lipoxin analogs and methods for the treatment of periodontal disease
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
AUPR101600A0 (en) Compositions and methods for diagnosis and treatment of cardiovascular disorders
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU2002363227A1 (en) Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
AU4225500A (en) Methods and compositions for the treatment and prevention of lung disease
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2002239505A1 (en) Methods and compositions for the diagnosis and treatment of viral disease using 55092
AU2002348324A1 (en) Methods and compositions for the treatment and diagnosis of pain disorders using 46566
AU2002232433A1 (en) Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3
AU2001241778A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular, hepatic, and bone disease
AU2002359316A1 (en) Methods and compositions for the diagnosis and treatment of hematological disorders using 16319
AU2002357675A1 (en) Methods and compositions for the diagnosis and treatment of hematological disorders using 2777